Citation Impact
Citing Papers
The mevalonate pathway regulates microRNA activity in Caenorhabditis elegans
2012 StandoutNobel
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Current research on acute phase proteins in veterinary diagnosis: an overview
2003 Standout
Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2 Only Aggregation, of Low Density Lipoprotein (LDL) Particles
1998
Oxidative stress, aging, and diseases
2018 Standout
Acute phase proteins in dogs and cats: current knowledge and future perspectives
2005 Standout
Phospholipase A2s: Developing drug targets for atherosclerosis
2010
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial
2009
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
2006
Lipoprotein modification by secretory phospholipase A2 enzymes contributes to the initiation and progression of atherosclerosis
2009
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress
2005
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Rationale and use of near-infrared spectroscopy for detection of lipid-rich and vulnerable plaques
2007
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality
2012
Future Role for Selective Phospholipase A2 Inhibitors in the Prevention of Atherosclerotic Cardiovascular Disease
2009
From Membrane Differential Filtration to Lipidfiltration: Technological Progress in Low‐density Lipoprotein Apheresis
2003
Serum amyloid A, the major vertebrate acute‐phase reactant
1999
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Modified HDL: Biological and physiopathological consequences
2006
Drug repurposing: progress, challenges and recommendations
2018 Standout
Adipokines: inflammation and the pleiotropic role of white adipose tissue
2004 Standout
Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?
2006
Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
2005
The phospholipase A2 superfamily and its group numbering system
2006 Standout
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
2011
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
2006 StandoutNobel
Regulation of type V phospholipase A2 expression and function by proinflammatory stimuli
1999
Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes
2002
Structure of low density lipoprotein (LDL) particles: Basis for understanding molecular changes in modified LDL
2000
Phospholipase A2 Modification of Lipoproteins: Potential Effects on Atherogenesis
2002
Atherosclerosis
2019 Standout
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
2002
Type 2 diabetes mellitus
2015 Standout
The expanding superfamily of phospholipase A2 enzymes: classification and characterization
2000 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Atherosclerosis
2000 StandoutNature
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate
2002
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Effect of Post-Treatment Techniques on Corrosion and Wettability of Hydroxyapatite-Coated Co–Cr–Mo Alloy
2015
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Copper Active Sites in Biology
2014 Standout
Advanced Glycation End Products
2006 Standout
Macrophage-Expressed Group IIA Secretory Phospholipase A 2 Increases Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice
2003
Lipoprotein-Associated Phospholipase A 2 , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions
1999
Novel biomarkers for cardiovascular risk prediction.
2017
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
2004
Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors
2003 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Gibberellin conjugates: an overview
1994
Using the shortwave infrared to image middle ear pathologies
2016 StandoutNobel
Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition
2004
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis
2016
Drug Therapy in the Heart Transplant Recipient
2005
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
2015 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Macrophage foam cells and atherosclerosis
2001
The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes Society
2001
Role of Group II Secretory Phospholipase A 2 in Atherosclerosis
1999
Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications
2017 Standout
Role of Group II Secretory Phospholipase A2in Atherosclerosis
1999
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Mechanisms of Diabetic Complications
2013 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Gibberellin Metabolism and its Regulation
2008 Standout
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Laboratory Evaluation of Pheochromocytoma and Paraganglioma
2014
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Role of Monocytes in Atherogenesis
2003
Statin Therapy in Acute Coronary Syndromes
2002
Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatographytandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma
2013
β-Arrestins Regulate Atherosclerosis and Neointimal Hyperplasia by Controlling Smooth Muscle Cell Proliferation and Migration
2008 StandoutNobel
Antiinflammatory Properties of HDL
2004 Standout
Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease
1998
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Group V sPLA 2 Hydrolysis of Low-Density Lipoprotein Results in Spontaneous Particle Aggregation and Promotes Macrophage Foam Cell Formation
2004
Circulating Levels of Secretory Type II Phospholipase A 2 Predict Coronary Events in Patients with Coronary Artery Disease
1999
Works of Peter Lattke being referenced
Impact of concentrations of glycated hemoglobin, α-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjects
1996
Release of Cobalt and Chromium Ions Into the Serum Following Implantation of the Metal-on-Metal Maverick-Type Artificial Lumbar Disc (Medtronic Sofamor Danek)
2007
Pharmacokinetics and Pharmacodynamics of Fluvastatin in Heart Transplant Recipients Taking Cyclosporine A
2001
Determination of the cholesterol–collagen ratio of arterial atherosclerotic plaques using near infrared spectroscopy as a possible measure of plaque stability
2002
Determination of cholesterol in atherosclerotic plaques using near infrared diffuse reflection spectroscopy
1999
Changes in epitope exposition of apolipoprotein A-I on the surface of high density lipoproteins after phospholipase A2 treatment
1995
Secretory group II phospholipase A2 in human atherosclerotic plaques
1995
Oxidation of Apolipoprotein B-100 in Circulating LDL Is Related to LDL Residence Time
2000
Formation of GA20 glucosyl conjugates in seedlings ofVicia faba
1985
Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma
2012
Exposure of macrophages to PLA2-modified lipoproteins leads to cellular lipid accumulations.
1995
Modification of lipoproteins by group II phospholipase A2 secreted by cytokine-stimulated HepG2 cells
1994
Immunohistochemical localisation of a secretory group-II phosholipase A2 in human atherosclerotic plaques
1995
Levodopa therapy in Parkinson’s disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine
2013